Jingjin HE ; Thanutra ZHANG ; Xuemei FU
Protein & Cell 2017;8(11):848-852
Acquired Immunodeficiency Syndrome ; genetics ; therapy ; CRISPR-Cas Systems ; Genetic Therapy ; methods ; Humans